$3.96
-4.5%Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Chief Accounting Officer
Compensation
$341,783
Chief Financial Officer
Compensation
$513,333
Chief Information Officer
Chief Legal Officer, General Counsel & Secretary
Compensation
$438,800
Chief Operating Officer
Compensation
$468,633
Chief People Officer
Chief Technology Officer
Co-Founder, Chief Executive Officer & Director
Compensation
$813,800
President
Compensation
$603,334
Vice President of Investor Relations
During the last 12 months, insiders have purchased $38K and sold $26K worth of EVH shares, resulting in $13K of net buying activity.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
10.0K
38.20K
0
0.00
+38K
+$38K
0
0.00
2.6K
25.62K
-26K
-$26K
Springstubb Brendan B
Director
$38K
Shams Aammaad
Officer: Chief Accounting Officer
$26K
Moderately bullish with $13K net buying. Insiders show cautious optimism through measured share purchases.
Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.
1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.
EVH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 24, 2026 | June 04, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | June 05, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | June 06, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 28, 2023 | April 28, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | June 09, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 30, 2021 | June 10, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 29, 2020 | June 09, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 30, 2019 | June 11, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 27, 2018 | June 13, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 27, 2017 | June 08, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.